TY - JOUR
T1 - Effects of Treatment of Coronavirus Disease 2019 With Convalescent Plasma in 25 B-Cell-Depleted Patients
AU - Gharbharan, Arvind
AU - GeurtsvanKessel, Corine H.
AU - Jordans, Carlijn C E
AU - Blaauw, Marc
AU - van der Klift, Marjolein
AU - Hassing, Robert-Jan
AU - Smits-Zwinkels, Marijn
AU - Meertens, Maaike
AU - van den Hout, Ella C
AU - de Man, Anne Marie
AU - Hageman, Ilse
AU - Bogers, Susanne
AU - van der Schoot, C. Ellen
AU - Swaneveld, Francis
AU - Anas, Adam A
AU - Rokx, Casper
AU - Rijnders, Bart J A
N1 - Publisher Copyright:
© 2021 The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.
PY - 2022/4/1
Y1 - 2022/4/1
N2 - Twenty-five B-cell-depleted patients (24 following anti-CD19/20 therapy) diagnosed with coronavirus disease 2019 had been symptomatic for a median of 26 days but remained antibody negative. All were treated with convalescent plasma with high neutralizing antibody titers. Twenty-one (84%) recovered, indicating the potential therapeutic effects of this therapy in this particular population.
AB - Twenty-five B-cell-depleted patients (24 following anti-CD19/20 therapy) diagnosed with coronavirus disease 2019 had been symptomatic for a median of 26 days but remained antibody negative. All were treated with convalescent plasma with high neutralizing antibody titers. Twenty-one (84%) recovered, indicating the potential therapeutic effects of this therapy in this particular population.
UR - http://www.scopus.com/inward/record.url?scp=85128487730&partnerID=8YFLogxK
U2 - 10.1093/cid/ciab647
DO - 10.1093/cid/ciab647
M3 - Article
C2 - 34293119
SN - 1058-4838
VL - 74
SP - 1271
EP - 1274
JO - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
IS - 7
ER -